Project 523

Project 523 is a pharmaceutical research program initiated by the People's Republic of China in 1967. The project's primary goal was to discover new drugs for the treatment of malaria. The project is best known for the discovery of artemisinin and dihydroartemisinin, two drugs that have become the most effective treatments for malaria.

History

Project 523 was launched on May 23, 1967, during the Cultural Revolution. The project was named after the date of its initiation (5/23). The project was a response to the urgent need for new treatments for malaria, which was a major health problem in China and North Vietnam at the time.

The project involved more than 500 scientists and was divided into two parts. The first part focused on the screening of traditional Chinese herbs for potential anti-malarial activity. The second part focused on the chemical synthesis of new anti-malarial drugs.

Discovery of Artemisinin

The major breakthrough of Project 523 came in the early 1970s when Tu Youyou, a pharmaceutical chemist, discovered artemisinin. Tu and her team extracted the drug from the plant Artemisia annua, also known as sweet wormwood. Artemisinin and its derivatives have been found to be particularly effective against the malaria parasite Plasmodium falciparum, which is responsible for the most severe form of malaria.

Impact

The discovery of artemisinin has had a significant impact on global health. The World Health Organization (WHO) recommends artemisinin-based combination therapies (ACTs) as the first-line treatment for uncomplicated P. falciparum malaria. Artemisinin and its derivatives have saved millions of lives worldwide.

See also

• History of malaria
• Antimalarial medication
• Traditional Chinese medicine

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

Project 523

• 
•